Skip to main navigation
About
Overview
Leadership
Board of directors
Contact
Science
Programs
THB335
Chronic urticaria
Severe asthma
Clinical Trials
Investors & Media
Overview
Press releases
Events & presentations
Analyst coverage
Governance
SEC filings
Financial results
Annual Report
Careers
Overview
Values
Culture Video
Benefits
Open roles
Event Details
Raymond James BioPharma CEO Strategy Series
10/18/2024 at 10:00 AM EDT
Listen to webcast
Print
Contact IR
RSS
Email alerts
